<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title> &#187; molecular biology</title>
	<atom:link href="http://pharmaexecnews.com/tag/molecular-biology/feed/" rel="self" type="application/rss+xml" />
	<link>http://pharmaexecnews.com</link>
	<description></description>
	<lastBuildDate>Fri, 29 Apr 2011 14:00:12 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.4</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Gene &#8216;Relocation&#8217; Key to Most Evolutionary Change in Bacteria</title>
		<link>http://pharmaexecnews.com/biotechnology/gene-relocation-key-evolutionary-change-bacteria/</link>
		<comments>http://pharmaexecnews.com/biotechnology/gene-relocation-key-evolutionary-change-bacteria/#comments</comments>
		<pubDate>Mon, 07 Feb 2011 08:00:44 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Genomics]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Proteomics]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[Bioinformatics Market Potential]]></category>
		<category><![CDATA[biomolecules]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[molecular biology]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11139</guid>
		<description><![CDATA[In a new study, scientists at the University  of Maryland and the Institut Pasteur show that bacteria evolve new abilities, such as antibiotic resistance, predominantly by acquiring genes from other bacteria. The researchers new insights into the evolution of bacteria partly contradict the widely accepted theory that new biological functions in bacteria and other [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/gene-relocation-key-evolutionary-change-bacteria/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Human Fetal Immune System Arises from Entirely Different Source than Adult Immune System</title>
		<link>http://pharmaexecnews.com/biotechnology/human-fetal-immune-system-arises-source-adult-immune-system/</link>
		<comments>http://pharmaexecnews.com/biotechnology/human-fetal-immune-system-arises-source-adult-immune-system/#comments</comments>
		<pubDate>Mon, 03 Jan 2011 08:00:31 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Genomics]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[embryonic stem cell research]]></category>
		<category><![CDATA[gene]]></category>
		<category><![CDATA[Gene therapy]]></category>
		<category><![CDATA[genetics]]></category>
		<category><![CDATA[molecular biology]]></category>
		<category><![CDATA[understanding stem cell research]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11032</guid>
		<description><![CDATA[UCSF researchers have shown for the first time that the human fetal immune system arises from an entirely different source than the adult immune system, and is more likely to tolerate than fight foreign substances in its environment.  The finding could lead to a better understanding of how newborns respond to both infections and vaccines, [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/human-fetal-immune-system-arises-source-adult-immune-system/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Alzheimer&#8217;s: Tau Disrupts Neural Communication Prior to Neurodegeneration</title>
		<link>http://pharmaexecnews.com/biotechnology/alzheimers-tau-disrupts-neural-communication-prior-neurodegeneration/</link>
		<comments>http://pharmaexecnews.com/biotechnology/alzheimers-tau-disrupts-neural-communication-prior-neurodegeneration/#comments</comments>
		<pubDate>Wed, 29 Dec 2010 08:00:42 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Central Nervous System]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[molecular biology]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11027</guid>
		<description><![CDATA[A new study is unraveling the earliest events associated with neurodegenerative diseases characterized by abnormal accumulation of tau protein. The research reveals how tau disrupts neuronal communication at synapses and may help to guide development of therapeutic strategies that precede irreversible neuronal degeneration.

Tau normally contributes to the supportive framework of proteins in the cell. It [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/alzheimers-tau-disrupts-neural-communication-prior-neurodegeneration/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>World&#8217;s First Stem Cell Trial for Strokes</title>
		<link>http://pharmaexecnews.com/biotechnology/worlds-stem-cell-trial-strokes/</link>
		<comments>http://pharmaexecnews.com/biotechnology/worlds-stem-cell-trial-strokes/#comments</comments>
		<pubDate>Tue, 28 Dec 2010 08:00:48 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[embryonic stem cell research]]></category>
		<category><![CDATA[molecular biology]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[understanding stem cell research]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=11014</guid>
		<description><![CDATA[The UK&#8217;s ReNeuron has been given a regulatory green light to launch the world&#8217;s first human trial of a stem cell therapy for strokes.  Beginning in the second quarter of this year, researchers for the biotech will begin to see exactly how stroke victims respond to the neural stem cell therapy, which researchers say could [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/worlds-stem-cell-trial-strokes/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Unraveling Alzheimer&#8217;s: Simple Small Molecules Could Untangle Complex Disease</title>
		<link>http://pharmaexecnews.com/biotechnology/unraveling-alzheimers-simple-small-molecules-untangle-complex-disease/</link>
		<comments>http://pharmaexecnews.com/biotechnology/unraveling-alzheimers-simple-small-molecules-untangle-complex-disease/#comments</comments>
		<pubDate>Mon, 20 Dec 2010 08:00:11 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Devices and Technology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[c reactive protein]]></category>
		<category><![CDATA[molecular biology]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10986</guid>
		<description><![CDATA[New molecular tools developed at the University of Michigan show promise for &#8220;cleansing&#8221; the brain of amyloid plaques, implicated in Alzheimer&#8217;s disease.

A hallmark of Alzheimer&#8217;s disease &#8212; a neurodegenerative disease with no cure &#8212; is the aggregation of protein-like bits known as amyloid-beta peptides into clumps in the brain called plaques. These plaques and their [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/unraveling-alzheimers-simple-small-molecules-untangle-complex-disease/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Molecule Increases Survival of Stomach Cancer Patients</title>
		<link>http://pharmaexecnews.com/biotechnology/molecule-increases-survival-stomach-cancer-patients/</link>
		<comments>http://pharmaexecnews.com/biotechnology/molecule-increases-survival-stomach-cancer-patients/#comments</comments>
		<pubDate>Wed, 20 Oct 2010 08:00:53 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Genomics]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[biomolecules]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cancer therapies]]></category>
		<category><![CDATA[molecular biology]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10809</guid>
		<description><![CDATA[Stomach cancer patients with a high expression of the molecule microRNA 451 show greater survival rates. This molecule could be a biomarker for treatment response. &#8220;The high presence of microRNA 451 enhances the response to treatment with chemo-radiotherapy and increases the survival of patients with stomach cancer,&#8221; explained Dr. Jesús García-Foncillas, chief researcher of the [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/molecule-increases-survival-stomach-cancer-patients/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cockroach Brains May Be a Source of Antibiotics</title>
		<link>http://pharmaexecnews.com/biotechnology/cockroach-brains-source-antibiotics/</link>
		<comments>http://pharmaexecnews.com/biotechnology/cockroach-brains-source-antibiotics/#comments</comments>
		<pubDate>Thu, 16 Sep 2010 08:00:07 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Disease]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[General News]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[biomolecules]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[molecular biology]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10707</guid>
		<description><![CDATA[Cockroach brains may be a source of new antibiotics capable of killing deadly drug-resistant bacteria, according to research that suggests the germ-spreading pests may be good for something after all. Insects such as cockroaches have a defense mechanism against bacteria, a “logical” development from living in unhygienic conditions, research from the U.K.’s University of Nottingham [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/cockroach-brains-source-antibiotics/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>First Genetic Link to Common Migraine Found</title>
		<link>http://pharmaexecnews.com/biotechnology/genetic-link-common-migraine/</link>
		<comments>http://pharmaexecnews.com/biotechnology/genetic-link-common-migraine/#comments</comments>
		<pubDate>Tue, 07 Sep 2010 08:00:03 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Companies]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[General News]]></category>
		<category><![CDATA[Genomics]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[International News]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Medical]]></category>
		<category><![CDATA[Medical Patents]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[Bioinformatics Market Potential]]></category>
		<category><![CDATA[biomolecules]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[gene]]></category>
		<category><![CDATA[Gene therapy]]></category>
		<category><![CDATA[genetics]]></category>
		<category><![CDATA[micro technology]]></category>
		<category><![CDATA[molecular biology]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Strategic Alliances in World Pharma and Biotech Markets]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10678</guid>
		<description><![CDATA[The results suggest that a buildup of that chemical, called glutamate, may play a role in the mechanism of migraines. An international scientific team has identified for the first time a genetic risk factor associated with common migraines and say their research could open the way for new treatments to prevent migraine attacks.

Researchers who looked [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/genetic-link-common-migraine/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>&#8216;Nanotox&#8217; Research also has Implications for Nano Drug Delivery</title>
		<link>http://pharmaexecnews.com/biotechnology/nanotox-research-implications-nano-drug-delivery/</link>
		<comments>http://pharmaexecnews.com/biotechnology/nanotox-research-implications-nano-drug-delivery/#comments</comments>
		<pubDate>Wed, 01 Sep 2010 08:00:34 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Drug Delivery]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[General News]]></category>
		<category><![CDATA[Government Policy]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Nanotechnology]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[Bioinformatics Market Potential]]></category>
		<category><![CDATA[biomolecules]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[micro technology]]></category>
		<category><![CDATA[molecular biology]]></category>
		<category><![CDATA[nano]]></category>
		<category><![CDATA[nanobiotechnology]]></category>
		<category><![CDATA[nanotechnology]]></category>
		<category><![CDATA[Nanotechnology - Revolutionizing R&D to Develop Smarter Therapeutics and Diagnostics]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10665</guid>
		<description><![CDATA[A relatively recent subgroup of nanotech research is what is beginning to be commonly referred to as &#8220;nanotox,&#8221; or the study of how nanoparticles react to the environment and human body. It is a line of inquiry that directly arose out of concerns that if engineered nanoscale particles have the potential to do great things [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/nanotox-research-implications-nano-drug-delivery/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Feds Aim to Fortify Biodefense by Fixing Product Development Pipeline</title>
		<link>http://pharmaexecnews.com/biotechnology/feds-aim-fortify-biodefense-fixing-product-development-pipeline/</link>
		<comments>http://pharmaexecnews.com/biotechnology/feds-aim-fortify-biodefense-fixing-product-development-pipeline/#comments</comments>
		<pubDate>Mon, 30 Aug 2010 08:00:09 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Bioinformatics]]></category>
		<category><![CDATA[Biomedical]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Drug Delivery]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Financial]]></category>
		<category><![CDATA[General News]]></category>
		<category><![CDATA[Government Policy]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[Industry News]]></category>
		<category><![CDATA[Industry News Alerts]]></category>
		<category><![CDATA[Infectious Diseases]]></category>
		<category><![CDATA[Market News]]></category>
		<category><![CDATA[Markets]]></category>
		<category><![CDATA[Medical Research]]></category>
		<category><![CDATA[New Drugs]]></category>
		<category><![CDATA[Pharmaceuticals]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Research Reports]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[Virus]]></category>
		<category><![CDATA[biochip]]></category>
		<category><![CDATA[biochips]]></category>
		<category><![CDATA[bioengineering]]></category>
		<category><![CDATA[Bioinformatics Market Potential]]></category>
		<category><![CDATA[biotech]]></category>
		<category><![CDATA[biotech industry]]></category>
		<category><![CDATA[biotech news]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[biotechnology news]]></category>
		<category><![CDATA[molecular biology]]></category>
		<category><![CDATA[nanobiotechnology]]></category>
		<category><![CDATA[Nanotechnology - Revolutionizing R&D to Develop Smarter Therapeutics and Diagnostics]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[Strategic Alliances in World Pharma and Biotech Markets]]></category>
		<category><![CDATA[Understanding the Global Biotech Industry]]></category>
		<category><![CDATA[Understanding the Global Pharmaceutical Market]]></category>

		<guid isPermaLink="false">http://pharmaexecnews.com/?p=10659</guid>
		<description><![CDATA[A leaky product development pipeline is hampering the country&#8217;s ability to ensure a steady output of new medical countermeasures, such as medications, vaccines, equipment and supplies needed for health emergencies, HHS Secretary Kathleen Sebelius said.

She spoke at the unveiling of a report that reviewed the federal government&#8217;s system for producing medical countermeasures and recommended fixes [...]]]></description>
		<wfw:commentRss>http://pharmaexecnews.com/biotechnology/feds-aim-fortify-biodefense-fixing-product-development-pipeline/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

